Concentrix is trading 5.4% down at $23.55, giving back part of yesterday’s double-digit rebound following a steep post-earnings plunge.
- The stock remains under pressure following its late-June fiscal Q2 report and a sharply reduced 2026 outlook, which initially triggered a more than 20% drop.
- Today's move appears to be a continued repricing as investors digest the softer guidance and an index-related overhang rather than fresh news.